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Abstract
Opioid-associated environmental stimuli elicit robust immune-altering effects via stimulation of a
neural circuitry that includes the basolateral amygdala and nucleus accumbens. These brain
regions are known to have both direct and indirect connections with the hippocampus. Thus, the
present study evaluated whether the dorsal hippocampus (DH), and more specifically interleukin-1
beta (IL-1β) within the DH, is necessary for the expression of heroin-induced conditioned
immunomodulation. Rats received five Pavlovian pairings of systemic heroin administration (1.0
mg/kg, SC) with placement into a distinct environment (conditioned stimulus, CS). Six days after
conditioning, a GABAA/B agonist cocktail or IL-1β small interfering RNA (siRNA) was
microinfused into the DH to inhibit neuronal activity or IL-1β gene expression prior to CS or
home cage exposure. Control animals received saline or negative control siRNA microinfusions.
Furthermore, all rats received systemic administration of lipopolysaccharide (LPS) to stimulate
proinflammatory nitric oxide production. CS exposure suppressed LPS-induced nitric oxide
production relative to home cage exposure. Inactivation of, or IL-1β silencing in, the DH disrupted
the CS-induced suppression of nitric oxide production relative to vehicle or negative control
siRNA treatment. These results are the first to show a role for DH IL-1β expression in heroin-
conditioned suppression of a proinflammatory immune response.
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Introduction
Opioids exert a number of detrimental physiological effects, including disruption of immune
system functioning, that diminish host defense mechanisms and increase susceptibility to
infectious disease states (Simonovska et al., 2011). For instance, acute heroin administration
results in the suppression of the peripheral proinflammatory mediator inducible nitric oxide
synthase (iNOS), the enzyme that is responsible for nitric oxide production (Lysle and How,
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2000). Nitric oxide production by immune cells, particularly macrophages, alters the course
of microbial resistance and autoimmune diseases (Breitbach et al., 2006; Choi et al., 2006;
Green et al., 1990; Green et al., 1993; MacMicking et al., 1995; Murray and Nathan, 1999;
Oates and Gilkeson, 2006; Rossi et al., 1999; Stofkova et al., 2006; Vincendeau et al., 1992;
Wei et al., 1995), provides resistance to viral infections and exerts significant tumor
cytotoxicity (Green et al., 1993; Hibbs et al., 1987; Hrabak et al., 2006; Karupiah et al.,
1993). Moreover, mice lacking the gene for iNOS exhibit increased susceptibility to
parasitic and bacterial infections (Lindgren et al., 2004; Wei et al., 1995), suggesting that
iNOS acts as an antimicrobial agent. In addition, nitric oxide has numerous
immunoregulatory functions, including the modulation of cytokine production
(Marcinkiewicz and Chain, 1993; Taylor-Robinson et al., 1994; Van Dervort et al., 1994)
and the suppression of lymphocyte proliferation (Albina and Henry, 1991). Thus, iNOS
plays a critical role in immune function and heroin-induced suppression of nitric oxide likely
increases susceptibility to infection following heroin administration.
Opioid-induced suppression of nitric oxide and other immune parameters are mediated by
central nervous system (CNS) mechanisms. Consistent with this, central administration of
the opioid antagonist, N-methylnaltrexone (a form of naltrexone which does not readily
penetrate the blood-brain barrier), attenuates the immunomodulatory effects of systemic
morphine treatment, whereas peripheral administration of N-methylnaltrexone is ineffective
(Fecho et al., 1996; Lysle et al., 1996). Furthermore, microinjection of morphine directly
into the periaqueductal gray, a brain region rich in opioid receptors, suppresses natural killer
(NK) cell cytotoxicity, an effect that can be blocked by peripheral administration of the
opioid antagonist naltrexone (Weber and Pert, 1989). Interestingly, following repeated
pairing with opioids, environmental stimuli can acquire the ability to induce alterations in
immune function similar to those produced by the drug itself (Coussons-Read et al., 1994a,
b; Coussons et al., 1992; Luecken and Lysle, 1992; Lysle et al., 1988; Lysle and Ijames,
2002; Szczytkowski et al., 2011; Szczytkowski and Lysle, 2007, 2008, 2010). These effects
are the result of Pavlovian conditioning, and research in our laboratory has identified the
basolateral amygdala (BLA) and the nucleus accumbens (NAC) as two brain regions
necessary for opioid-induced condition immunomodulation (Saurer et al., 2009;
Szczytkowski and Lysle, 2008). In support of this, D1 dopamine receptor antagonism in the
BLA inhibits conditioned decreases in the production of proinflammatory mediators in
peripheral immune tissues (Szczytkowski and Lysle, 2010). More recently, our laboratory
has shown that the integrity of a specific limbic neurocircuitry comprised of the BLA, NAC,
and ventral tegmental area (VTA) is required for heroin-conditioned immunosuppression
(*********Szczytkowski et al., 2011). Each of these brain regions has anatomical
connections with the hippocampus indicating the possibility that the hippocampus may also
play a role in conditioned immune alterations.
The hippocampus is a heterogeneous structure with compartmentalized functionality and
connectivity. In particular, the dorsal hippocampus (DH) is necessary for declarative, spatial,
and configural learning and memory as well as for “contextual-recall,” a form of memory
that is dependent upon environmental cues (Maren and Holt, 1999; Phillips and Ledoux,
1994; Redish, 2001). Thus, following heroin conditioning, the DH likely provides crucial
information about drug-associated environmental stimuli and facilitates conditioned
immunomodulation. Furthermore, interaction between the BLA and the DH is necessary for
the expression of context-induced drug-seeking behavior (Fuchs et al., 2005). As a regulator
of a number of conditioning processes, the DH appears to be a likely component of the
neural circuitry of heroin-induced conditioned immunomodulation. Accordingly,
Experiment 1 in the present study utilized GABA agonist-induced temporary inactivation of
the DH in order to investigate the hypothesis that the functional integrity of the DH is
required for the expression of heroin-induced conditioned immunosuppression.
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The second aim of the present study was to assess the role of the cytokine, interleukin-1 beta
(IL-1β), in the DH in heroin-induced conditioned immunosuppression. IL-1β is expressed
by glia and neurons in several regions of the brain including the hippocampus (McPherson
et al., 2011; Rothwell, 1991). Once viewed primarily as immune molecules that mediate
inflammatory events during pathology, cytokines are now recognized to be important
regulators of neuronal communication similar in action to neurotransmitters and
neuropeptides (Adler et al., 2005). Surprisingly little is known about brain cytokine
function; however, emerging research suggests that IL-1β is essential for a number of
behavioral processes, including learning and memory. For example, deletion of the IL-1
receptor type 1 (IL-1R1) gene results in impaired hippocampal-dependent learning and
memory function (Avital et al., 2003; Ben Menachem-Zidon et al., 2011; Goshen et al.,
2007; Schmid et al., 2009). Conversely, Pavlovian fear conditioning is associated with
increased IL-1 gene expression within the hippocampus (Goshen et al., 2007). Together,
these results suggest that optimal levels of IL-1β are required for proper hippocampal
function and memory processing, however, the role of hippocampal IL-1β in conditioned
immunomodulation has not yet been investigated. Thus, Experiment 2 in the present study
utilized small interfering RNA (siRNA) mediated IL-1β RNA interference in order to test




Male Lewis rats (Charles-River Laboratories), weighing 225–250 g, were housed
individually in a colony room under a reversed 12-hour day-night cycle, with free access to
food and water. Animals received a 2-week habituation period before experimentation and
were handled regularly during this time. All procedures were approved by the Institutional
Animal Care and Use Committee (IACUC) of the University of North Carolina at Chapel
Hill and conformed to the National Research Council’s Guide for the Care and Use of
Laboratory Animals (Institute of Laboratory Animal Resources on Life Sciences).
Surgical Procedures
Animals were anesthetized with a 1.0 ml/kg intraperitoneal injection of 9:1 (vol:vol)
ketamine hydrochloride (100 mg/ml) mixed with xylazine (100 mg/ml) and were placed into
the stereotaxic apparatus. Guide cannula (26-gauge, Plastics One, Roanoke, VA) were
directed bilaterally toward the DH (AP −3.4 mm, ML ±3.1 mm, DV s;2.15 mm, relative to
Bregma; 15° angle laterally; (Paxinos and Watson, 1998). Animals were given two weeks
for post-operative recovery.
Conditioning Procedure
Based on our prior studies (Szczytkowski et al., 2011; Szczytkowski and Lysle, 2010), rats
received five, 60 min conditioning sessions. Each session involved heroin administration
(diacetylmorphine dissolved in 0.9 % sterile saline; NIDA Drug Supply System, Bethesda,
MD) immediately followed by placement into a conditioning chamber (BRS/LVE, Laurel,
MD, USA; 26.7×24.8×30.7) that served as the conditioned stimulus (CS). A 1.0 mg/kg
subcutaneous dose of heroin was selected based on prior experiments in our laboratory
showing that this dosage alters LPS-induced iNOS mRNA expression in the spleen (Lysle
and How, 2000; Lysle and Ijames, 2002; Szczytkowski and Lysle, 2007). The conditioning
chambers were located in a room separate from the animal colony and contained a metal
grid floor and cedar bedding to create an environment distinct from the home cage. Six days
after conditioning, the rats were re-exposed to the conditioning chamber (CS) or remained in
their home cages (HC) for 60 min. Immediately thereafter, rats received a subcutaneous
Szczytkowski et al. Page 3













injection of LPS (1 μg/kg; serotype 055:B5, dissolved in sterile, pyrogen-free saline) to
induce in vivo production of nitric oxide. Rats were sacrificed 6 h later and a sample of
spleen and blood were obtained for the analysis of nitric oxide.
Prior work utilized a number of conditioning control groups to show systematically that the
conditioned effects observed in this paradigm are due to context exposure itself as opposed
to ancillary effects of the conditioning procedure. These control groups included a saline-
conditioned group that received saline injections paired with placement into the conditioning
chamber and an unpaired heroin-treated group that was conditioned with saline and received
heroin injections outside of the conditioning context (Lysle and Ijames, 2002). To conserve
animals, these negative control groups were not included in the present study.
Neuronal Inactivation
In Experiment 1, rats received bilateral intra-DH microinfusions (0.3 μl/hemisphere infused
over 1 min) of saline vehicle or a cocktail of baclofen and muscimol (0.3 nmol and 0.03
nmol, respectively) 30 min prior to CS or home cage exposure on the test day. This
combination of GABAB and GABAA agonists has been used extensively to transiently
disrupt neural activity in cell bodies within target brain regions, including the DH, without
affecting fibers of passage (Fuchs et al., 2007; Lasseter et al., 2011; Szczytkowski and
Lysle, 2008).
Injectors extended 2 mm beyond the tip of the guide cannula and were left in place for 1
minute after the injection to allow for proper diffusion away from the infusion site. Prior
experiments from our laboratory have shown no effect of inactivation of an anatomical
control region, the somatosensory cortex, that is located just dorsal relative to the DH, on
drug context- induced goal-directed behavior (Fuchs et al., 2005; Ramirez et al., 2009).
IL-1β silencing
For the siRNA experiment (Experiment 2) and verification (Experiment 3), rats received
intracranial microinfusions of negative control or IL-1β siRNA (both 5.6 pmol/0.7 μl/
hemisphere) into the DH 48 h prior to the test session in order to maximize IL-1β
knockdown at the time of testing. Following the infusion (0.23 μl/min), injectors were left in
place for 5 min. The procedure utilized three sets of siRNA designed to the rat IL-1β mRNA
sequence (NCBI Accession number: NM_031512.2) using Invitrogen’s BLOCK-iTtm RNAi
Express tool (Invitrogen; Pre-designed Stealth Select siRNA, HPLC purity). The sense
sequences of the IL-1β siRNA were 5′-CCAAAGUGGAGUUUGAGUCUGCACA-3′, 5′-
UUGUUCAUCUCGAAGCCUGCAGUGC-3′, and 5′-
ACUGUCCCUGAACUCAACUGUGAAA-3′, with the corresponding antisense sequences
5′-UGUGCAGACUCAAACUCCACUUUGG-3′, 5′-
GCACUGCAGGCUUCGAGAUGAACAA- 3′, and 5′-
UUUCACAGUUGAGUUCAGGGACAGU-3′, respectively. Multiple siRNA duplexes
were transfected to target different segments of the intended mRNA sequence, thereby
maximizing knock down efficiency (Chao et al., 2011). Additionally, two different sets of
missense negative control siRNA (Invitrogen; Med and Lo GC Negative Controls, HPLC
purity) were used that complemented the GC content of the IL-1β siRNAs. The sense
sequences used were 5′-AGCUACACUAUCGAGCAAUUAACUU-3′, 5′-
UUCCUCUCCACGCGCAGUACAUUUA-3′ and the corresponding antisense sequences,
5′-AAGUUAAUUGCUCGAUAGUGUAGCU-3′ and 5′-
UAAAUGUACUGCGCGUGGAGAGGAA-3′. All siRNA was complexed with jetSItm
(Polyplus Transfection Illkirch, Cat# 403-05), a cationic lipid transfection agent that
facilitates transfection into brain tissue in vivo, according to the manufacturer’s protocol.
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To determine iNOS mRNA expression, real-time qRT-PCR was performed on tissue
samples from the spleen. The spleen was analyzed because immunohistochemical
localization of iNOS in rats exposed to LPS shows the presence of the iNOS enzyme in a
number of immune cells found in the spleen, including macrophages, lymphocytes, and
neutrophils (Bandaletova et al., 1993). Total RNA was extracted using TRI-Reagent
(Molecular Research Center, Cincinnati, OH), a modification of the original method
described by Chomczynski and Sacchi (Chomczynski and Sacchi, 1987). RNA was
quantified spectrophotometrically (GeneQuant II, Pharmacia-Biotech, Piscataway, NJ,
USA). Reverse transcription was performed using Oligo(dT)18 primer and Moloney Murine
Leukemia Virus-Reverse transcriptase following the protocol of the Advantage RT-for-PCR
Kit from Clontech (Palo Alto, CA, USA). Specific products from the PCR reaction were
detected with Universal ProbeLibrary Probes (Roche, Indianapolis, IN). PCR amplifications
were performed using standard protocols, the LightCycler TaqMan Master Real-Time PCR
Kit and the LightCycler II instrument (Roche, Indianapolis, IN). A master mix containing all
reaction components was prepared and then 20 μl of cDNA with master mix was placed in
glass capillary tubes specifically designed for use in the LightCycler II system. Primers and
probes for iNOS were as follows: 5′-TGAGGATTACTTCTTCCAGCTCA-3′ and 5′-
TGGGTGTCAGAGTCTTGTGC-3′, using probe #25. Primers were synthesized by the
Nucleic Acids Core Facility (Lineberger Cancer Center, UNC-Chapel Hill). Copy numbers
were generated based on an internal standard curve. Amplifications were carried out for 45
cycles and curves showing fluorescence at each cycle were determined by the computer
software (Roche). Samples were pre-incubated for 10 min at 95° C to activate the Fast-Start
Taq DNA polymerase. The cycle temperatures were 95 and 60 °C and the cycle times were
10 and 30 s for the denaturing and annealing/extending, respectively. Fluorescence level was
determined at the end of the extending phase for each cycle of PCR. A final cooling phase
was carried out at 40° C for 30 s. The analysis of the fluorescence in standards and samples
over the course of 45 cycles was used to derive the number of copies of the target molecule
in each sample. Additionally, assessments of housekeeping gene expression, L13A, were
made to verify comparable RNA quality across samples. L13A primers were 5′-
CCCTCCACCCTATGACAAGA-3′ and 5′-GGTACTTCCACCCGACCTC-3′, with probe
#74. The data are expressed as iNOS copies per 10 ng cDNA based on a standard curve
using Roche LightCycler software.
Nitrite/nitrate assay
The nitrite/nitrate concentration in plasma samples was assessed using the Greiss reagent
assay as described previously (Szczytkowski and Lysle, 2007). Briefly, 6 μl of plasma
diluted in 44 μl of dH2O was incubated in the dark for 90 min with 10 μl of nitrate
reductase (1.0 U/ml), 20 μl of 0.31M phosphate buffer (pH 7.5), 10 μl of 0.86mM NADPH
(Sigma) and 10 μl of 0.11mM flavin adenine dinucleotide in individual wells of a 96-well
plate. Then, 200 ml of Greiss reagent, consisting of a 1:1 (v/v) solution 1% sulfanilamide in
5.0% phosphoric acid and 0.1% N-(1-napthyl) ethyl-enedamine dihydrochloride in distilled
water, was added to the samples. The color developed for 10 min at room temperature, after
which, the absorbance was determined using a spectrophotometer set at 550 nm. All
reactions were carried out in triplicate. The total micromolar concentration of nitrite was
determined for each sample based on a standard curve. Recovery of nitrate is greater than
95% using this assay.
Histology
To confirm proper cannula placement, Alcian blue dye was infused via the cannulae
following euthanasia. Brains were then extracted and post-fixed in a 4% paraformaldehyde
solution. Following fixation, the brains were transferred to 30% sucrose solution for
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cryoprotection. Coronal sections (50 μm) were taken and stained with cresyl violet for
verification of cannula placement using light microscopy.
Verification of siRNA effectiveness
The effectiveness of the intra-DH siRNA manipulation in inhibiting IL-1β expression was
validated in a separate group of rats. These rats received bilateral IL-1β siRNA or negative
control microinfusions into the DH using the infusion parameters as employed in experiment
2, followed 48 h later by systemic LPS administration (1.0 mg/kg) to induce hippocampal
IL-1β expression. The DH was harvested for real-time qRT-PCR analysis of IL-1β and
L13A (housekeeping gene) expression 4 h after LPS administration, as described previously.
Primers and probes for IL-1β were as follows: 5′-AGCTTCAGGAAGGCAGTGTC-3′ and
5′-TCCCACGAGTCACAGAGGA-3′, using probe #5. The data are expressed as IL-1β
copies per 10 ng cDNA based on a standard curve using Roche LightCycler software.
Statistical analysis
Analyses of variance (ANOVAs) or Student’s t-tests were performed on the data sets, when
appropriate. For all experiments, the significance level was set at 0.05. The source of
significant omnibus ANOVA effects was examined using Tukey’s post-hoc test.
Results
Experiment 1 investigated the effect of bilateral DH inactivation on the expression of
heroin-induced conditioned suppression of inducible nitric oxide synthase (iNOS), an
important peripheral proinflammatory mediator, in the spleen (Hibbs et al., 1987;
Vincendeau et al., 1992; Wei et al., 1995). Cannula placements were located bilaterally in
the DH (Figure 1). Rats received five Pavlovian conditioning trials during which a distinct
environment (conditioned stimulus, CS) was paired with systemic heroin administration. Six
days after conditioning, a test session was conducted during which the rats were re-exposed
to the previously heroin-paired environment (CS Exposed) or remained in their home cages
(HC) for 60 min. A GABAB/GABAA agonist cocktail (muscimol and baclofen, B/M;
0.3/0.03 nmol; 0.3 μl/hemisphere) or saline was microinfused into the DH 30 min prior to
the test session. Lipopolysaccharide (LPS, 1.0 mg/kg, SC) was administered immediately
after testing in order to induce nitric oxide production. Two indices of nitric oxide
production, iNOS mRNA expression in the spleen and nitrite/nitrate levels in blood plasma,
were assessed.
GABA agonist-induced neural inactivation of the DH inhibited the heroin-conditioned
suppression of iNOS mRNA in the spleen (Figure 2A). The omnibus ANOVA revealed a
difference between the four groups in LPS-induced iNOS copies [F(3,17) = 3.68, P<0.05].
Pairwise comparisons indicated that, following intra-DH saline pretreatment, splenic iNOS
mRNA expression was decreased upon exposure to the previously heroin-paired
environment relative to remaining in the home cage (Tukey test, P=0.028). Importantly,
following intra-DH B/M pretreatment, splenic iNOS mRNA expression did not differ
between the CS exposed and the home cage groups. There was no significant alteration in
housekeeping gene (L13A) expression between the groups (data not shown). Thus, B/M
treatment abolished the heroin-induced conditioned suppression in splenic iNOS mRNA
expression.
GABA agonist-induced neural inactivation of the DH also impaired heroin-induced
conditioned suppression of plasma nitrite/nitrate levels (Figure 2B). The omnibus ANOVA
revealed a difference between the four groups in plasma nitrite/nitrate levels [F(3,17) =
4.362, P<0.05]. Pair-wise comparisons indicated that plasma nitrite/nitrate concentration
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was decreased upon exposure to the previously heroin-paired environment relative to
remaining in the home cage (Tukey test, P=0.011), consistent with the iNOS mRNA
expression data. Conversely, following B/M pretreatment, plasma nitrite/nitrate
concentration did not differ upon exposure to the CS. Thus, B/M treatment disrupted the
heroin-conditioned reduction in plasma nitrite/nitrate concentration.
Experiment 2 investigated the role of DH interleukin-1 beta (IL-1β) in heroin-induced
conditioned suppression of peripheral proinflammatory mediators. As in Experiment 1,
cannula placements were located bilaterally within the DH (Figure 3). The experimental
procedures were the same as in Experiment 1 except that animals received intra-DH
microinfusions of negative control (missense) or IL-1β small interfering RNA (siRNA; both
5.6 pmol/0.7 μl/hemisphere) 48 h prior to exposure to the previously heroin-paired context
or the home cage.
siRNA-induced IL-1β RNA interference in the DH disrupted heroin-conditioned
suppression of iNOS in the spleen (Figure 4A). The omnibus ANOVA for iNOS copies
revealed a difference between the groups [F(3,19) = 4.95, P<0.05]. Pair-wise comparisons
indicated that, following negative control pretreatment in the DH, splenic iNOS mRNA
copies were decreased upon exposure to the previously heroin-paired environment compared
to remaining in the home cage (Tukey test, P=0.046). In contrast, following intra-DH IL-1β
sense siRNA pretreatment, splenic iNOS mRNA expression did not differ upon exposure to
the CS. There was no significant alteration in housekeeping gene (L13A) expression in the
groups (data not shown). Thus, IL-1β siRNA pretreatment disrupted the heroin-conditioned
reduction in splenic iNOS mRNA expression.
IL-1β RNA interference in the DH also inhibited the heroin-induced conditioned
suppression of plasma nitrite/nitrate levels (Figure 4B). The omnibus ANOVA for plasma
nitrite/nitrate levels revealed a difference between the groups [F(3,19) = 6.07, P<0.05].
Pairwise comparisons indicated that, following negative control pretreatment in the DH,
plasma nitrite/nitrate levels were decreased upon exposure to the previously heroin-paired
environment compared to remaining in the home cage (Tukey test, P=0.024). In contrast,
following intra-DH IL-1β siRNA pretreatment, plasma nitrite/nitrate concentration did not
differ upon exposure to the CS. Thus, IL-1β siRNA pretreatment disrupted the heroin-
conditioned reduction in plasma nitrite/nitrate levels.
The effectiveness of the intra-DH siRNA manipulation in blocking IL-1β expression in the
DH was validated in a separate group of rats (Figure 5). These rats received bilateral IL-1β
siRNA or negative control microinfusions into the DH using the infusion parameters
employed in Experiment 2, followed 48 h later by systemic LPS administration to induce
hippocampal IL-1β expression. The DH was harvested for real-time qRT-PCR analysis of
IL-1β expression 4 h after LPS administration. Intra-DH administration of IL-1β siRNA
decreased IL-1β copies in the DH relative to negative control administration [t(6)=3.516;
P<0.05]. There was no significant alteration in housekeeping gene (L13A) expression in the
groups (data not shown). Thus, intra-DH IL-1β siRNA pretreatment blocked the expression
of LPS-induced IL-1β in the DH.
Discussion
In the present study, both global neural inactivation of the dorsal hippocampus (DH) and
interleukin-1 beta (IL-1β) RNA interference within the DH impaired the ability of a heroin-
paired environment to suppress splenic iNOS mRNA expression and plasma nitrite/nitrate
levels, thereby rescuing nitric oxide production. Previous reports from our laboratory have
elucidated key brain regions and identified critical neural circuitry necessary for the
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expression of heroin-induced conditioned immunomodulation. The results of the current set
of experiments significantly expand this line of research by revealing the DH as another
necessary component of the neural circuitry mediating heroin-induced conditioned
immunomodulation. Furthermore, the results also reveal that IL-1β-mediated processes
within the DH mediate the conditioned suppression of LPS-induced nitric oxide production.
Nitric oxide is essential for the body’s defense against infectious challenge as its induction is
associated with protection against numerous pathogens, including bacteria, fungi, parasites,
and viruses (Liew, 1994; Tsai et al., 1997). Bacterial infections associated with injection
drug use account for more than one-third of drug-related hospital admissions and can
quickly progress to major systemic infection and cause severe damage to organs such as the
heart and lungs (Orangio et al., 1984; White, 1973). Since heroin use is associated with a
high incidence of opportunistic infections (Hussey and Katz, 1950; Louria et al., 1967;
Luttgens, 1949; Theodorou and Haber, 2005) and both heroin administration and exposure
to heroin-associated cues significantly reduce LPS-induced iNOS expression (Lysle and
How, 2000; Lysle and Ijames, 2002), drug-induced and drug-conditioned reductions in nitric
oxide production may be involved in this increased incidence of infectious disease. Thus, the
finding that these conditioned reductions in nitric oxide are mediated by IL-1β signaling in
the DH provides an important public health perspective. While the focus of the current study
was on splenic iNOS expression, it is likely that other immune parameters may also be
subject to alteration by inactivation or IL-1β suppression within the hippocampus. Previous
research from our laboratory has shown that inactivation of other key brain regions (i.e., the
BLA and NAC) attenuates conditioned immunomodulation across several immune
parameters, including peripheral expression of the cytokines TNF-α, IL-6 and IL-1
(Szczytkowski et al., 2011; Szczytkowski and Lysle, 2008).
The results of Experiment 1 in the present study demonstrate that the functional integrity of
the DH is necessary for conditioned immunomodulation. Temporary inactivation of the DH
blocked heroin conditioned suppression of LPS-induced nitric oxide production. The DH is
somewhat isolated from adjacent brain regions as it is surrounded by the lateral ventricle.
Furthermore, temporary neural inactivation of the dorsally overlying trunk region of the
somatosensory cortex, the brain region most likely in the path of inadvertent B/M infusion
away from the DH, fails to alter drug-induced conditioned behaviors, such as drug context-
induced cocaine seeking (Fuchs et al., 2005). This suggests that the intracranial
manipulations in the present study were anatomically selective to the DH and not due to B/
M diffusion to dorsal brain regions.
Previous reports from our laboratory have identified the basolateral amygdala (BLA),
nucleus accumbens (NAC), and ventral tegmental area (VTA) as responsible for mediating
conditioned immunomodulation (Szczytkowski et al., 2011). These brain regions are
extensively connected to one another and to the DH, providing anatomical basis for a
putative neural circuitry (Del-Fava et al., 2007; Ikemoto, 2007; Mcdonald, 1991). In support
of this, interaction between the DH and BLA is necessary for a cocaine-paired context to
induce drug-seeking behavior (Fuchs et al., 2005). Based on its well-known involvement in
spatial learning and memory (Fanselow and Dong, 2010), it is likely that the DH contributes
to heroin-induced conditioned immunomodulation within this circuitry by facilitating the
acquisition and expression of contextual associations.
Immune molecules, such as cytokines, can regulate neural processes including learning and
memory consolidation. IL-1β has been shown to critically mediate hippocampal-dependent
learning via the stimulation of IL-1 receptor type 1 (IL-1R1). IL-1 receptor antagonism
disrupts long-term potentiation (LTP), and mice lacking IL-1β or the IL-1R1 exhibit severe
memory deficits in hippocampal-dependent learning (Ben Menachem-Zidon et al., 2011;
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Goshen et al., 2007; Ross et al., 2003; Schneider et al., 1998). However,
pathophysiologically high levels of IL-1β, such as those observed following infection or
injury, are also disruptive to learning and memory processes and have been associated with
cognitive impairment in Alzheimer’s disease and Down Syndrome (Griffin et al., 1989). In
the current study, IL-1β RNA interference in the DH prevented peripheral
immunosuppression by the heroin-paired context. These results show that, similar to other
forms of learning, Pavlovian conditioned immunosuppression requires optimal levels of
IL-1β within the hippocampus and that impaired IL-1 signaling blocks the expression of the
conditioned effect. Additional studies would have to determine whether this effect is related
to interference with memory retrieval processes that are utilized during reexposure to the CS
or block effector processes necessary for peripheral immune modulation.
The cellular effects of IL-1β are cell specific within the hippocampus. Within the DH,
several cell types are capable of producing IL-1β, and both neurons and glia express IL-1
receptors (Yabuuchi et al., 1994; Zhang et al., 2010). In astrocytes, IL-1β initiates the
formation of IL-1β signaling intermediates, such as interleukin-1 receptor-associated kinase
(IRAK; (Flannery and Bowie, 2010; Ringwood and Li, 2008) and the subsequent activation
of p38, extracellular signal-regulated kinase (ERK) and nuclear factor kappa-light-chain-
enhancer of activated B cells (NFkB;(Guasch et al., 2007; Huang et al., 2011). Conversely,
in hippocampal neurons, IL-1β activates p38 and ERK, but not NFkB (Huang et al., 2011).
In addition to IRAK-mediated mechanisms, ERK activation can occur via the IL-1R1-
mediated activation of Src family tyrosine kinases and N-methyl-D-aspartic acid (NMDA)
glutamate receptor-mediated signaling cascades (Bertotto et al., 2011; Davis et al., 2006;
Tsakiri et al., 2008; Viviani et al., 2003). Once activated, ERK and p38 translocate into the
nucleus and initiate the transcription of immediate-early genes (e.g., c-Fos, c-Jun) and IL-1β
responsive genes and facilitate the stabilization of these transcripts (Weber et al., 2010;
Zhang et al., 2010). Furthermore, NFkB and the mitogen-activated protein kinase, c-Jun N-
terminal kinase (JNK), may be important in immunomodulation via their effects on
hypothalamic-pituitary-adrenal (HPA) axis function. Complex interactions between cell
types and multiple signaling cascades likely gives rise to a nuanced control over immune
function by IL-1β. Thus, future studies will need to characterize the phenotype of DH cells
that produce or respond to IL-1β and the IL-1β-mediated intracellular signaling pathways
that control heroin-induced conditioned immunosuppression.
Overall, the results reported here indicate that IL-1β within the DH plays a critical role in
heroin-induced conditioned immunomodulation. Given that conditioned immunosuppression
is a drug-like conditioned effect, heroin may also elicit immunosuppression in an IL-1β-
dependent fashion. However, the DH may be uniquely critical for the integration of
contextual information for conditioned, but not for the unconditioned, heroin effects. Future
comparisons between the role of IL-1β in conditioned and unconditioned
immunosuppression will therefore enhance our understanding of each phenomenon.
Meanwhile, the results of the present study identify a mechanism by which nitric oxide, a
molecule critical for proper immune functioning, can be inhibited following exposure to
previously heroin-paired environmental stimuli and suggest that IL-1β may be a target for
the development of pharmacotherapies that restore immune function in former and current
opioid users.
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Overall, the results reported here indicate that IL-1β within the dorsal hippocampus plays
a critical role in heroin-induced conditioned immunomodulation.
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Injection cannula placement in experiment 1 as verified by light microscopy and mapped
onto schematics from the rat brain atlas of Paxinos and Watson (Paxinos and Watson, 1998).
Symbols represent the most ventral point of injection cannula tracts for each animal that
received bilateral vehicle (Sal) or B/M microinfusions into the DH following exposure to the
previously heroin-paired context (CS) or the home cage (HC). Numbers indicate the distance
from bregma in mm. Symbols: CS + Sal, open squares; CS + B/M, filled squares; HC + Sal,
open circles; HC + B/M, filled circles
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Effects of GABA agonist-induced inactivation of the DH on indices of LPS-induced nitric
oxide production. A: Splenic iNOS mRNA expression (mean copies per 10 ng cDNA +
SEM) assessed based on a standard curve using Roche LightCycler software, following
bilateral intra-DH administration of vehicle (Sal) or GABAA/B agonists (B/M; 0.3/0.03 nmol
per 0.3 μl/hemisphere) and exposure to the previously heroin-paired context (CS) or the
home cage (HC). B: Plasma nitrate/nitrite levels (mean micromolar concentration of nitrate/
nitrite + SEM) as determined by the Greiss reagent assay. (*) Asterisks indicate significant
difference relative to the Sal + HC group (Tukey test, p<0.05).
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Injection cannula placement in experiment 2 as verified by light microscopy and mapped
onto schematics from the rat brain atlas of Paxinos and Watson (Paxinos and Watson, 1998).
Symbols represent the most ventral point of injection cannula tracts for each animal that
received bilateral negative control or IL-1β siRNA following exposure to the previously
heroin-paired context (CS) or the home cage (HC). Numbers indicate the distance from
bregma in mm. Symbols: CS + Neg Con, open squares; CS + siRNA, filled squares; HC +
Neg Con, open circles; HC + siRNA, filled circles
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Effects of IL-1β RNA interference on indices of LPS-induced nitric oxide production. A:
Splenic iNOS mRNA expression (mean copies per 10 ng cDNA + SEM) assessed following
bilateral intra-DH administration of negative control or IL-1β siRNA (both 5.6 pmol/0.7 μl/
hemisphere) and exposure to the previously heroin-paired context (CS) or the home cage
(HC). B: Plasma nitrate/nitrite levels (mean micromolar concentration of nitrate/nitrite +
SEM) as determined by the Greiss reagent assay. (*) Asterisks indicate significant difference
relative to the Saline + HC group (Tukey test, p<0.05).
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Effects of the IL-1β siRNA manipulation on LPS-induced IL-1β mRNA expression (mean
copies per 10 ng cDNA + SEM). Negative control or IL-1β siRNA (both 5.6 pmol/0.7 μl/
hemisphere) was administered into the DH 4 h prior to LPS administration, and DH tissue
was harvested 4 h thereafter. (*) Asterisk indicates a significant difference relative to
negative control (Student’s t-test, p<0.05).
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